RenovaCare Stock Forecast, Price & News

+0.12 (+13.38 %)
(As of 09/23/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1,220 shs
Average Volume15,144 shs
Market Capitalization$88.84 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RCAR News and Ratings via Email

Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter.

RenovaCare logo

About RenovaCare

RenovaCare, Inc. operates as a development stage company, which focuses on research, development, and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. Its flagship technology is the CellMist System, which is comprised of a treatment methodology for cell isolation for the regeneration of human skin cells and other tissues; and a solution sprayer device for delivering cells to the treatment area. The company was founded on July 14, 1983 and is headquartered in Roseland, NJ.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.91 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

RenovaCare (OTCMKTS:RCAR) Frequently Asked Questions

What stocks does MarketBeat like better than RenovaCare?

Wall Street analysts have given RenovaCare a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but RenovaCare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting RenovaCare?

RenovaCare saw a drop in short interest in August. As of August 31st, there was short interest totaling 7,200 shares, a drop of 76.8% from the August 15th total of 31,000 shares. Based on an average trading volume of 40,500 shares, the short-interest ratio is currently 0.2 days.
View RenovaCare's Short Interest

When is RenovaCare's next earnings date?

RenovaCare is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.
View our earnings forecast for RenovaCare

How were RenovaCare's earnings last quarter?

RenovaCare, Inc. (OTCMKTS:RCAR) released its quarterly earnings results on Tuesday, August, 3rd. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter.
View RenovaCare's earnings history

How has RenovaCare's stock been impacted by COVID-19 (Coronavirus)?

RenovaCare's stock was trading at $1.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RCAR stock has decreased by 27.4% and is now trading at $1.0170.
View which stocks have been most impacted by COVID-19

Who are RenovaCare's key executives?

RenovaCare's management team includes the following people:
  • Kaiyo Nedd, President, Chief Executive Officer & Director
  • Justin Frere, Chief Financial Officer, Secretary & Treasurer
  • Roger Esteban-Vives, Vice President-Research & Product Development
  • Robin A. Robinson, Chief Scientific Officer
  • Jo Ellen Schweinle, Chief Medical Officer

What other stocks do shareholders of RenovaCare own?

What is RenovaCare's stock symbol?

RenovaCare trades on the OTCMKTS under the ticker symbol "RCAR."

How do I buy shares of RenovaCare?

Shares of RCAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RenovaCare's stock price today?

One share of RCAR stock can currently be purchased for approximately $1.02.

How much money does RenovaCare make?

RenovaCare has a market capitalization of $88.84 million.

How many employees does RenovaCare have?

RenovaCare employs 3 workers across the globe.

What is RenovaCare's official website?

The official website for RenovaCare is www.renovacareinc.com.

Where are RenovaCare's headquarters?

RenovaCare is headquartered at 4 BECKER FARM ROAD SUITE 105, ROSELAND NJ, 07068.

How can I contact RenovaCare?

RenovaCare's mailing address is 4 BECKER FARM ROAD SUITE 105, ROSELAND NJ, 07068. The biotechnology company can be reached via phone at (888) 398-0202.

This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.